Alignment Healthcare shares upgraded to overweight by Piper Sandler, price target raised to $8.00.
Alignment Healthcare (NASDAQ: ALHC) shares were upgraded to an overweight rating by Piper Sandler, with a new $8.00 price target, up from $6.00. The company reported a 43.1% year-over-year increase in revenue, but posted a negative net margin of 7.81% and a negative return on equity of 91.06%. The consensus rating for ALHC is a moderate buy, with a consensus price target of $8.69.
May 11, 2024
3 Articles